Literature DB >> 30092160

The controversies surrounding polypharmacy in old age - where are we?

Kristina Johnell1.   

Abstract

Keywords:  Polypharmacy; editorial; elderly; geriatrics; pharmacoepidemiology

Mesh：

Substances：

Year:  2018        PMID： 30092160     DOI： 10.1080/17512433.2018.1510313

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  5 in total

1.  Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult mice.

Authors:  Francesca Eroli; Kristina Johnell; María Latorre Leal; Chiara Adamo; Sarah Hilmer; Jonas W Wastesson; Angel Cedazo-Minguez; Silvia Maioli
Journal:  Aging (Albany NY)       Date:  2020-05-22       Impact factor: 5.682

2.  Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.

Authors:  Laurie E Davies; Andrew Kingston; Adam Todd; Barbara Hanratty
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

3.  Prevalence and impact of potentially inappropriate medication on community-dwelling older adults.

Authors:  Alejandra Fernández; Fernando Gómez; Carmen-Lucía Curcio; Edison Pineda; Juliana Fernandes de Souza
Journal:  Biomedica       Date:  2021-03-19       Impact factor: 0.935

Review 4.  Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.

Authors:  Farhad Pazan; Martin Wehling
Journal:  Eur Geriatr Med       Date:  2021-03-10       Impact factor: 1.710

5.  Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice.

Authors:  Eroli Francesca; Johnell Kristina; Latorre-Leal María; Hilmer Sarah; Wastesson Jonas; Cedazo-Minguez Angel; Maioli Silvia
Journal:  Aging (Albany NY)       Date:  2021-06-02       Impact factor: 5.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.